Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
16 September 2016
E-006916-16
Question for written answer
to the Commission
Rule 130
Marian Harkin (ALDE) , Kay Swinburne (ECR) , Karin Kadenbach (S&D)

 Subject:  Health systems
 Answer(s) 

Member State health systems are currently facing a rising demand for services and increasing costs to meet patients’ demands. To help address these challenges, the Commission has engaged in several activities, such as the Health Systems Performance Assessment (HSPA) Working Group or the analysis and measuring of national healthcare systems’ performances in order to formulate country recommendations as part of the European Semester.

Will the Commission consider direct engagement initiatives with stakeholders in the framework of the Expert Group on HSPA?

How does the Commission assess investment at national level in research and innovation in health systems?

Does the Commission plan to focus significantly more on innovative (technology-based) policy initiatives in order to attain its goals?

Last updated: 6 October 2016Legal notice